(0.97%) 5 059.03 points
(0.56%) 38 454 points
(1.32%) 15 656 points
(0.44%) $82.26
(-0.95%) $1.774
(-0.46%) $2 335.60
(-0.40%) $27.14
(-0.98%) $922.20
(-0.41%) $0.935
(-0.40%) $10.94
(-0.78%) $0.803
(-0.18%) $93.24
@ $5.48
Issued: 14 Feb 2024 @ 15:23
Return: -17.08%
Previous signal: Feb 14 - 12:19
Previous signal:
Return: 1.96 %
Live Chart Being Loaded With Signals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema...
Stats | |
---|---|
Today's Volume | 1.17M |
Average Volume | 3.11M |
Market Cap | 935.92M |
EPS | $0 ( 2024-02-26 ) |
Next earnings date | ( $-0.220 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.85 |
ATR14 | $0.0160 (0.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Thackray Helen M. | Sell | 7 525 | Common Stock |
2024-02-29 | Milano Vincent | Buy | 999 | Common Stock |
2024-02-29 | Heggie Theresa | Buy | 999 | Common Stock |
2024-01-03 | Stonehouse Jon P | Sell | 20 000 | Common Stock |
2024-01-03 | Stonehouse Jon P | Buy | 10 000 | Common Stock |
INSIDER POWER |
---|
75.01 |
Last 100 transactions |
Buy: 4 343 991 | Sell: 822 588 |
Volume Correlation
BioCryst Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
NAKD | 0.945 |
SNGX | 0.941 |
GSMG | 0.94 |
MICS | 0.938 |
CSSEP | 0.932 |
TENX | 0.931 |
GRNA | 0.931 |
IRBT | 0.93 |
BCYC | 0.93 |
BHTG | 0.928 |
10 Most Negative Correlations | |
---|---|
GXII | -0.959 |
MLTX | -0.944 |
NCAC | -0.944 |
LMNR | -0.944 |
VPCB | -0.943 |
TETC | -0.941 |
LMRKO | -0.939 |
PPYAU | -0.938 |
FTPA | -0.937 |
CRZN | -0.936 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BioCryst Pharmaceuticals Correlation - Currency/Commodity
BioCryst Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $331.41M |
Gross Profit: | $325.10M (98.09 %) |
EPS: | $-1.180 |
Q4 | 2023 |
Revenue: | $93.40M |
Gross Profit: | $91.34M (97.79 %) |
EPS: | $-0.310 |
Q3 | 2023 |
Revenue: | $86.74M |
Gross Profit: | $85.61M (98.69 %) |
EPS: | $-0.190 |
Q2 | 2023 |
Revenue: | $82.49M |
Gross Profit: | $81.54M (98.85 %) |
EPS: | $-0.400 |
Financial Reports:
No articles found.
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators